Hormone Sensitive Prostate Cancer Market Segments, Opportunity, Growth and Forecast by End-use Industry 2016-2026

Hormone Sensitive
Prostate Cancer Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016
Future Market Insights
www.futuremarketinsights.com
[email protected]
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research Capabilities
Sector Coverage








Customized Research
Syndicated Research
Investment Research
Social Media Research
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Customized
Research
Subscription Information
Syndicated
Research
For detailed subscription information please contact
Investment
Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media
Research
Hari. T (Sr. Manager - Global Business Development)
Email: [email protected]




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Report
Description
Report Description
Prostate cancer is a general term used for diseased condition in which abnormal cells
grow and invade in uncontrolled manner in the prostate. Prostate cancer inhibits
production of male sex hormones (i.e. androgens) and ultimately blocks the action of
androgen. The androgen is also responsible for the growth of prostate cancer. Androgen
binds with the receptors and stimulates the expression of specific genes that would be
responsible for prostate cancer. However, androgen suppression hormonal therapies are
commonly used for the treatment of this cancer. These therapies acts by reducing the
production of androgen by the testicles or by blocking the action of androgen in the
body. There is an opportunity for the growth of hormone sensitive prostate cancer owing
to the rapidly aging population which is the major cause of prostate cancer.
Hormone Sensitive Prostate Cancer Market: Drivers and Restraints
Increasing incidence of hormone sensitive prostate cancers and availability of various
treatment modalities like surgery, radiation therapy and cryosurgery are the major factors
driving the growth of hormone sensitive prostate cancer treatment market globally. The
driving factor of hormone sensitive prostate cancer market is the. Advancement in
technology, personalized medicine, cost effective treatment procedures are few other
factors expected provide boost to global hormone sensitive prostate cancer treatment
market. However, limited commercially availability drugs and treatments for this cancer is
the challenge restraining the growth of global hormone sensitive prostate cancer
treatment market.
Report
Description
Report Description
Request free sample Report: http://www.futuremarketinsights.com/reports/sample/repgb-1375
Hormone Sensitive Prostate Cancer Market: Segmentation
The global hormone sensitive prostate cancer market has been segmented on the basis
of treatment, end use and geography.
Based on treatment, the global hormone sensitive prostate cancer market is segmented
into:
• Androgen Ablation Therapy
• Anti-androgens
• Chemotherapy
• Targeted Therapy
• Cryotherapy
Based on end user type, the global hormone sensitive prostate cancer market is
segmented into:
• Hospitals
• Clinics
• Cancer Rehabilitation Centers
Report
Description
Report Description
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1375
Hormone Sensitive Prostate Cancer Market: Regional Overview
Geographically, the global hormone sensitive prostate cancer market is classified into
regions namely, North America, Latin America, Western Europe, Eastern Europe, AsiaPacific, Japan, Middle East and Africa.North America takes the largest share of global
hormone sensitive cancer treatment market followed by Europe. The global hormone
sensitive prostate cancer treatment market is expected to grow in future due to
increasing investment by multinational companies in cancer research.
Hormone Sensitive Prostate Cancer Market: Key Players
Some of the key players in hormone sensitive prostate cancer market are Novartis
Pharmaceuticals, Merc & Co., Inc., Bristol-Myers, Dendreon Corporation, GlaxoSmithKline
plc., Ferring International Center S.A., Roche group, Celgen Corporation, Amgen Inc., Teva
pharmaceutical Industries Ltd., Bayer AG, and Pfizer Inc.
Browse full report: http://www.futuremarketinsights.com/reports/hormone-sensitiveprostate-cancer-market
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact: Mr. Sudip Saha
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705